Ganitumab: all 28 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent SarcomaRecruitingNCT04199026Not applicable
- Palbociclib + Ganitumab In Ewing SarcomaTerminatedNCT04129151Phase 2Results posted
- Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar RhabdomyosarcomaTerminatedNCT03041701Phase 1/2Results posted
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing SarcomaActive, not recruitingNCT02306161Phase 3Results posted
- A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid TumorsTerminatedNCT01708161Phase 1/2Results posted
- Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)CompletedNCT01327612Phase 2Results posted
- Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the PancreasTerminatedNCT01318642Phase 2Results posted
- QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the PancreasCompletedNCT01231347Phase 3Results posted
- AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine TumorsCompletedNCT01024387Phase 2Results posted
- Study to Evaluate Mechanisms of Acquired Resistance to PanitumumabCompletedNCT00891930Phase 2Results posted
- QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid TumorsTerminatedNCT00819169Phase 1/2Results posted
- QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung CancerTerminatedNCT00807612Phase 1/2Results posted
- QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung CancerTerminatedNCT00791154Phase 1/2Results posted
- Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)CompletedNCT00788957Phase 1/2Results posted
- Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian CancerCompletedNCT00719212Phase 2Results posted
- Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian CancerTerminatedNCT00718523Phase 2Results posted
- QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerCompletedNCT00630552Phase 1/2Results posted
- QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast CancerCompletedNCT00626106Phase 2Results posted
- A Study of MEK162 and AMG 479 in Patients With Selected Solid TumorsTerminatedNCT01562899Phase 1/2
- Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on TrastuzumabWithdrawnNCT01479179Phase 1/2
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic CancerWithdrawnNCT01473303Phase 1/2
- Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the PancreasCompletedNCT01298401Phase 1
- Study of RAD001 + AMG479 for Patients With Advanced Solid TumorsCompletedNCT01122199Phase 1
- A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007CompletedNCT01061788Phase 1
- QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCompletedNCT00974896Phase 1
- QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal CarcinomaCompletedNCT00813605Phase 2
- QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell TumorsCompletedNCT00563680Phase 2
- AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaCompletedNCT00562380Phase 1